Eli Lilly and Co
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Eli Lilly and Co in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Eli Lilly and Co.
Recent articles on PMLiVE featuring Eli Lilly and Co
Around 60,000 people in the US get pancreatic cancer each year, with an estimated 50,000 deaths projected annually
The acquisition will advance therapies for treatment-resistant depression and other mental health conditions
This new option for patients allows for as few as six maintenance injections per year
The acquisitions reinforce the company’s commitment to reduce the long-term burden of serious disease
The acquisition will help build Lilly’s infectious disease portfolio
Six-year initiative to improve NCD prevention and care for children in low- and middle-income countries
The company has also opened its first dedicated genetic medicine facility in Indiana in the US
The acquisition will help Lilly to expand its capabilities in cell and gene therapy
The agreement covers the development of new lead tau morphomer candidates
The companies aim to advance treatments for narcolepsy and other sleep-wake disorders
Taken at any time of the day, the oral GLP-1 is the only pill to have no food or water restrictions
Kilcoyne previously held senior roles at AstraZeneca, Celgene, Sanofi, Roche and Eli Lilly
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology